RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • FDA panel recommends continued Avandia sales, with restrictions

    FDA panel recommends continued Avandia sales, with restrictions
    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...
  • Nigeria may have no polio cases next year, says Bill Gates

    NAIROBI (Reuters) - Nigeria could cut the number of polio cases to zero next year and be declared free of the disease in 2018 even though a national eradication campaign has had to contend with an insurgency in the north, Bill Gates told Reuters. The...
  • Drugmakers to share neglected compounds with British academia

    LONDON (Reuters) - A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening ties between industry and external scientists. British...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
  • U.S. HPV vaccination rates far from goal, officials say

    U.S. HPV vaccination rates far from goal, officials say
    WASHINGTON (Reuters) - Only slightly more than half of U.S. girls aged 13 to 17 had been vaccinated against a virus that can cause cervical and other cancers last year, and a top U.S. health official said on Thursday that more must be done to bring the...
  • Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

    LONDON/MUMBAI (Reuters) - Indian generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline (GSK) , five sources familiar...
  • Blood tests could detect sexually-transmitted oral cancers

    Blood tests could detect sexually-transmitted oral cancers
    LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of...
  • EU advises all girls need cervical cancer vaccines

    EU advises all girls need cervical cancer vaccines
    LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...
  • Avandia review by FDA examines whether dangers were overdrawn

    Avandia review by FDA examines whether dangers were overdrawn
    Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions. The...
  • AstraZeneca raises forecasts after seeing off Pfizer

    LONDON (Reuters) - AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach from rival Pfizer two months ago. Second-quarter sales and earnings both beat...
  • Impax Parkinson's drug future shaky as FDA flags factory issues

    (Reuters) - Impax Laboratories Inc said the U.S. Food and Drug Administration raised concerns about the company's factory in Taiwan, casting in doubt the future of its Parkinson's drug, rytary. Shares of Impax, which makes generics and specialty drugs to...